Immuneering Ownership | Who Owns Immuneering?
Immuneering Ownership Summary
Immuneering is owned by 72.37% institutional investors, 19.96% insiders, and 7.68% retail investors. Fmr is the largest institutional shareholder, holding 24.42% of IMRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.97% of its assets in Immuneering shares.
IMRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immuneering | 72.37% | 19.96% | 7.68% |
| Sector | Healthcare Stocks | 42.64% | 10.86% | 46.50% |
| Industry | Biotech Stocks | 45.45% | 10.77% | 43.78% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 8.79M | 24.42% | $61.51M |
| Sanofi | 2.71M | 6.83% | $17.82M |
| Empery asset management, lp | 2.67M | 6.74% | $17.60B |
| Vanguard group | 2.57M | 6.47% | $16.90M |
| Citadel advisors | 1.88M | 6.41% | $2.41M |
| Price t rowe associates inc /md/ | 1.80M | 5.00% | $12.59M |
| Exoduspoint capital management, lp | 1.52M | 4.22% | $10.62M |
| Blackrock funding, inc. /de | 1.45M | 3.66% | $9.55M |
| Logos global management lp | 950.00K | 2.64% | $6.65M |
| Blackrock | 533.36K | 1.82% | $682.71K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Empery asset management, lp | 2.67M | 15.52% | $17.60B |
| Southport management | 272.50K | 7.87% | $1.91M |
| Sanofi | 2.71M | 5.74% | $17.82M |
| Diametric capital, lp | 252.19K | 0.65% | $1.77M |
| Logos global management lp | 950.00K | 0.60% | $6.65M |
| Dcf advisers | 215.00K | 0.38% | $1.41M |
| Blue owl capital lp | 665.00K | 0.33% | $4.38M |
| Flower city capital | 42.23K | 0.14% | $277.87K |
| Burkehill global management, lp | 300.00K | 0.12% | $2.10M |
| Exoduspoint capital management, lp | 1.52M | 0.11% | $10.62M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 8.79M | 0.00% | 8.57M |
| Empery asset management, lp | 2.67M | 15.52% | 2.67M |
| Price t rowe associates inc /md/ | 1.80M | 0.00% | 1.80M |
| Exoduspoint capital management, lp | 1.52M | 0.11% | 1.52M |
| Logos global management lp | 950.00K | 0.60% | 950.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Cormorant asset management, lp | - | - | -3.30M |
| Blackrock | 533.36K | - | -843.76K |
| Marshall wace, llp | 271.30K | 0.00% | -302.56K |
| Monashee investment management | - | - | -300.00K |
| Iridian asset management llc/ct | - | - | -275.09K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Empery asset management, lp | 2.67M | 15.52% | 2.67M | $17.60B |
| Exoduspoint capital management, lp | 1.52M | 0.11% | 1.52M | $10.62M |
| Logos global management lp | 950.00K | 0.60% | 950.00K | $6.65M |
| Goldman sachs group | 318.81K | 0.00% | 318.81K | $2.10M |
| Burkehill global management, lp | 300.00K | 0.12% | 300.00K | $2.10M |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Nisa investment advisors | -10.00 |
| Point72 (difc) | -16.00 |
| Sbi securities | -74.00 |
| Farther finance advisors | -80.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 68 | 74.36% | 26,041,962 | 580.01% | 72 | 62.29% | 56 | 194.74% | 7 | 16.67% |
| Jun 30, 2025 | 39 | 14.71% | 3,829,641 | -14.87% | 10 | 6.72% | 19 | 46.15% | 6 | -33.33% |
| Mar 31, 2025 | 3 | -92.86% | 288,934 | -93.28% | - | 0.39% | 2 | -89.47% | 1 | -90.00% |
| Dec 31, 2024 | 23 | -39.47% | 2,290,179 | -47.42% | 7 | 3.60% | 9 | -40.00% | 5 | -70.59% |
| Sep 30, 2024 | 38 | -30.91% | 4,355,311 | -54.58% | 14 | 1.37% | 15 | -58.33% | 17 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 707.17K | 1.97% | -15.62K |
| T. Rowe Price Health Sciences | 431.83K | 1.20% | -6.52K |
| Fidelity Select Biotechnology | 383.78K | 0.90% | 222.78K |
| Vanguard Institutional Extnd Mkt Idx Tr | 269.10K | 0.75% | -20.10K |
| Fidelity Extended Market Index | 135.77K | 0.32% | 15.10K |
| Extended Equity Market Fund K | 77.01K | 0.21% | 77.01K |
| TD Health Sciences - I | 75.44K | 0.21% | - |
| NT R2000 Index Fund - NL | 60.79K | 0.20% | -260.00 |
| NT R2000 Growth Index Fund - NL | 52.97K | 0.18% | - |
| NT R2000 Index Fund - DC - NL - 2 | 48.11K | 0.16% | -378.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 16, 2026 | Brakewood Harold Eugene | Chief Business Officer | Buy | $24.99K |
| Jan 15, 2026 | Schall Thomas J. | - | Buy | $101.04K |
| Jan 15, 2026 | Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER | Buy | $10.50K |
| Jan 13, 2026 | Neufeld Leah R | CHIEF PEOPLE OFFICER | Buy | $10.91K |
| Jan 12, 2026 | Feinberg Peter | - | Buy | $86.90K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | 5 | - |
| 2025 Q4 | 4 | - |
| 2025 Q3 | 7 | - |
| 2025 Q2 | 7 | - |
| 2025 Q1 | - | - |
IMRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools